MRD / Regn No. : SG001138 Date : 23/07/2026
Patient Name : Abdul Mannan Age & Gender : 56 Yrs. / Male
Contact No. : 01711664648 UHID :
Ht / Wt / BMI : 163 / 72 / 27.10 BP S / BP D : 131 / 89
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (27/Apr/2015) |
Salient Investigations : TGL TRIGLYCERIDE: 48 mg/dL | FASTING PLASMA GLUCOSE (FPG): 263 mg/dL | HB HEMOGLOBIN: 14.2 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 12.7 % | LDL LOW DENSITY LIPOPROTEIN: 54 mg/dL | MICROALBUMIN CREATININE RATIO: 19.4 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET TELMISARTAN 40 MG
APEL 40
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
2 TABLET ROSUVASTATIN 20 MG
STATEZE R 20
PO 0-0-1 BEFORE DINNER
TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR
PO 1-0-1 BEFORE BREAKFAST AND DINNER
TILL NEXT VISIT
4 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
ZEXRIDA L
PO 1-0-0 BEFORE BREAKFAST
TILL NEXT VISIT
5 ANTIHYPERGLYCEMIC INSULIN ICODEC (700UNITS/1ML)
AWIQLI
SC 0-0-210 ONCE A WEEK
DAY 1 ONLY
6 ANTIHYPERGLYCEMIC INSULIN ICODEC (700UNITS/1ML)
AWIKLI FOLLOW UP DOSE
SC 0-0-140 ONCE A WEEK (BEDTIME)
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 23/Jan/2027
Tests Suggested For Next Visit : CHECK FASTING AND PP SUGAR AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,LIPID PROFILE (RANDOM),UACR:SPOT SAMPLE,RETINA CHECK UP
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: